Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
p52-/p36- GAP Vaccine for Malaria Prevention
NCT01024686Phase 2Terminated
- Sponsor
- Seattle Children's
- Start
- Mar 2010
- Primary completion
- Jun 2011
- Countries
- 1
01
Overview
A Phase 2 trial of p52-p36- GAP vaccine in malaria, sponsored by Seattle Children's. Started Mar 2010; status: terminated.
02
Drugs
p52-p36- GAP vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01024686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024686.